$PBIO The integrated workflow of LMD and PCT was d
Post# of 23572
![Avatar](/images/ProfileImages/754971288_289_stock market picture.jpg)
Dr. Conrads said: "We believe that integrating LMD, PCT, and MS will improve our understanding of the complex tissue microenvironment and better enable identification of new biomarkers. We believe that the insights gained from applying this novel workflow will result in significant improvements in the clinical management of gynecologic and other cancers."
The global cancer biomarker market is expected to reach $136.5 billion by 2023.
https://www.nasdaq.com/press-release/pressure...nce%3A-the
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)